Hyperthermia therapy is FDA-approved to destroy cancerous cells when combined with radiation therapy or chemotherapy.
Hyperthermia therapy is FDA-approved to destroy cancerous cells when combined with radiation therapy or chemotherapy.

The ultrasonic heat technology used in hyperthermia treatments at HCI effectively weakens cancer cells. When paired with radiation therapy and chemotherapy, hyperthermia amplifies their potency. Because of consistent rates of success, hyperthermia is integrated into cancer care more each year.
An increased blood flow allows for a higher concentration of cancer-destroying radiation or chemicals to infiltrate the tumor. This surge in blood flow is caused by heat generated from targeted ultrasonic waves. In hyperthermia treatments, a specialized ultrasonic machine steadily heats the tumor to 109°F (43°C) over the course of 45 minutes.
When paired with chemotherapy or radiation therapy, hyperthermia treatments reduce cancer cells’ ability to repair DNA damage. At the same time, the heat boosts the body’s immune system into attacking the weakened cancer cells. The one-two punch of radiation therapy/chemotherapy and hyperthermia strengthens your body’s defenses as well as the power of the existing cancer treatment while debilitating the tumor. This creates the most ideal path toward complete tumor eradication.
When combatting an illness as complex and unpredictable as cancer, a multi-pronged approach is stronger than a singular one. Combining hyperthermia therapy with existing cancer treatments ensures that a patient receives the most comprehensive defense against cancerous cells.
This improved method of cancer care enables your body to fight back, increases the impact of the existing cancer treatment, and breaks down the tumor’s defenses. It can also reduce the chances of treatment-resistant cancer cells from developing.
Certain types of cancer are more complex than others, and they, unfortunately, tend to be more resistant to treatment. Over 35 years of research have shown that combining hyperthermia treatments with radiation therapy and chemotherapy improves the likelihood of a complete response with hard-to-beat cancers, without any additional side effects. Each patient that HCI partners with undergoes a screening with our medical director Dr. Joseph Pinzone. During the screening, Dr. Pinzone reviews the patient’s medical history and conducts an examination. If hyperthermia therapy seems beneficial for the patient, Dr. Pinzone partners with the patient’s oncology team to create an appropriate treatment plan.